An Analysis of Polymorphisms Within the Wnt Signaling Pathway in Relation to Ovarian Cancer Risk in a Polish Population

Overview

Journal Mol Diagn Ther

Specialties Molecular Biology
Pathology
Pharmacology

Date 2013 Oct 1

PMID 24078348

Citations 21

Authors

Adrianna Mostowska

Piotr Pawlik

Stefan Sajdak

Janina Markowska

Monika Pawalowska

Margarita Lianeri

Pawel P Jagodzinski

Affiliations

Soon will be listed here.

Abstract

Background And Objective: The Wnt/β-catenin signaling pathway has been considered to be a factor in the development and progression of ovarian cancer.

Methods: All patients with ovarian cancer and controls were tested for BRCA1 mutations (5382incC, C61G, 4153delA) with HybProbe assays and for BRCA2 mutation (5946delT) using high-resolution melting curve analysis (HRM). Mutation carriers were excluded from the association analysis. We studied nine single nucleotide polymorphisms (SNPs) located in CTNNB1 (β-catenin) [rs4533622, rs2953], APC (rs11954856, rs351771, rs459552), and AXIN2 (rs4074947, rs7224837, rs3923087, rs2240308) in women with ovarian cancer without BRCA1/BRCA2 mutations (n = 228) and controls (n = 282). Genotyping of CTNNB1 rs4533622, rs2953, APC rs351771, AXIN2 rs4074947, rs3923087, and rs2240308 was performed by HRM, while that of APC rs11954856, rs459552 and AXIN2 rs7224837 was conducted by PCR followed by the appropriate restriction enzyme digestion [PCR–restriction fragment length polymorphism (PCR-RFLP)].

Results: The most common BRCA1/BRCA2 mutations were identified in 30 patients with ovarian cancer. These mutations were not found in controls. The lowest p values of the trend test (p trend) were observed for the APC rs351771 and rs11954856 SNPs in patients with ovarian cancer (p trend = 0.006 and p trend = 0.007, respectively). Using a dominant inheritance model, we found that the APC rs11954856 SNP is associated with an increased risk of ovarian cancer development [odds ratio = 2.034 (95 % CI 1.302–3.178); p = 0.002]. We also observed significant allelic differences for the APC rs351771 SNP between patients and controls (p = 0.006).

Conclusion: Our study demonstrated significantly increased APC rs11954856 and rs351771 SNP frequencies in Polish women with ovarian cancer.

Citing Articles

Structural variant landscapes reveal convergent signatures of evolution in sheep and goats.

Yang J, Wang D, Huang J, Zhu Q, Luo L, Lu R Genome Biol. 2024; 25(1):148.

PMID: 38845023 PMC: 11155191. DOI: 10.1186/s13059-024-03288-6.

and Their Natural Flavonoid Compounds in the Treatment of Ovarian Cancer: A Review.

Cai J, Hu Q, He Z, Chen X, Wang J, Yin X Molecules. 2023; 28(13).

PMID: 37446743 PMC: 10343681. DOI: 10.3390/molecules28135082.

Plant-Derived Chinese Medicine Monomers on Ovarian Cancer via the Wnt/-Catenin Signaling Pathway: Review of Mechanisms and Prospects.

Xu J, Liu F, Liu S, Xie L, Li J, Ma Y J Oncol. 2021; 2021:6852867.

PMID: 34912456 PMC: 8668291. DOI: 10.1155/2021/6852867.

New insights of the correlation between AXIN2 polymorphism and cancer risk and susceptibility: evidence from 72 studies.

Li X, Li Y, Liu G, Wu W BMC Cancer. 2021; 21(1):353.

PMID: 33794810 PMC: 8017882. DOI: 10.1186/s12885-021-08092-0.

The Association of Polymorphisms in Base Excision Repair Genes with Ovarian Cancer Susceptibility in Chinese Women: A Two-Center Case-Control Study.

Zhang M, Zhao Z, Chen S, Liang Z, Zhu J, Zhao M J Cancer. 2021; 12(1):264-269.

PMID: 33391423 PMC: 7738827. DOI: 10.7150/jca.49925.

References

Wright K, Wilson P, Morland S, Campbell I, Walsh M, Hurst T . beta-catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours. Int J Cancer. 1999; 82(5):625-9. DOI: 10.1002/(sici)1097-0215(19990827)82:5<625::aid-ijc1>3.0.co;2-2. View

Choi Y, Shim H, Gao M, Kang S, Cho N . Molecular portraits of intratumoral heterogeneity in human ovarian cancer. Cancer Lett. 2011; 307(1):62-71. DOI: 10.1016/j.canlet.2011.03.018. View

Dudbridge F . Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered. 2008; 66(2):87-98. PMC: 2386559. DOI: 10.1159/000119108. View

Wang X, Goode E, Fredericksen Z, Vierkant R, Pankratz V, Liu-Mares W . Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2008; 17(8):2101-8. PMC: 2771409. DOI: 10.1158/1055-9965.EPI-08-0134. View

Nakamura T, Hamada F, ISHIDATE T, Anai K, Kawahara K, Toyoshima K . Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level. Genes Cells. 1998; 3(6):395-403. DOI: 10.1046/j.1365-2443.1998.00198.x. View

Vainio S, Heikkila M, Kispert A, Chin N, McMahon A . Female development in mammals is regulated by Wnt-4 signalling. Nature. 1999; 397(6718):405-9. DOI: 10.1038/17068. View

Nyholt D . A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet. 2004; 74(4):765-9. PMC: 1181954. DOI: 10.1086/383251. View

Starker L, Fonseca A, Fonseca A, Akerstrom G, Bjorklund P, Westin G . Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas. Endocrine. 2012; 42(3):612-5. DOI: 10.1007/s12020-012-9690-3. View

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T . Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2):71-96. DOI: 10.3322/CA.2007.0010. View

10.

Gershoni-Baruch R, Patael Y, Dagan , Figer A, Kasinetz L, Kadouri E . Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: more questions than answers. Br J Cancer. 2000; 83(2):153-5. PMC: 2363478. DOI: 10.1054/bjoc.2000.1248. View

11.

Saegusa M, Okayasu I . Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J Pathol. 2001; 194(1):59-67. DOI: 10.1002/path.856. View

12.

Herr P, Hausmann G, Basler K . WNT secretion and signalling in human disease. Trends Mol Med. 2012; 18(8):483-93. DOI: 10.1016/j.molmed.2012.06.008. View

13.

Kanzaki H, Ouchida M, Hanafusa H, Yano M, Suzuki H, Aoe M . Single nucleotide polymorphism of the AXIN2 gene is preferentially associated with human lung cancer risk in a Japanese population. Int J Mol Med. 2006; 18(2):279-84. View

14.

Notaridou M, Quaye L, Dafou D, Jones C, Song H, Hogdall E . Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer. 2010; 128(9):2063-74. PMC: 3098608. DOI: 10.1002/ijc.25554. View

15.

ABRAHAMSON J, Moslehi R, Vesprini D, Karlan B, Fishman D, Smotkin D . No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews. Cancer Res. 1998; 58(14):2919-22. View

16.

Novak A, Dedhar S . Signaling through beta-catenin and Lef/Tcf. Cell Mol Life Sci. 2001; 56(5-6):523-37. PMC: 11146752. DOI: 10.1007/s000180050449. View

17.

Gunes E, Pinarbasi E, Pinarbasi H . AXIN2 polymorphism and its association with astrocytoma in a Turkish population. Mol Med Rep. 2011; 3(4):705-9. DOI: 10.3892/mmr_00000321. View

18.

Hsieh M, Johnson M, Greenberg N, Richards J . Regulated expression of Wnts and Frizzleds at specific stages of follicular development in the rodent ovary. Endocrinology. 2002; 143(3):898-908. DOI: 10.1210/endo.143.3.8684. View

19.

Guerreiro C, Cravo M, Brito M, Vidal P, Fidalgo P, Leitao C . The D1822V APC polymorphism interacts with fat, calcium, and fiber intakes in modulating the risk of colorectal cancer in Portuguese persons. Am J Clin Nutr. 2007; 85(6):1592-7. DOI: 10.1093/ajcn/85.6.1592. View

20.

Wu R, Zhai Y, Fearon E, Cho K . Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res. 2001; 61(22):8247-55. View